To further verify, the impact of anti-DLL4-conjugated TNPs on SSIL2Rγ- and SS.BN3IL2Rγ- rats were implanted with another triple negative breast cancer cells HCC-1806 (1806RLUC+) in the inguinal mammary fat pad. The gene discussed is DLL4; the disease is triple-negative breast carcinoma.